Publication | Open Access

SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination

VaccinationTransplantationVaccine DevelopmentBooster EffectSars-cov-2 InfectionImmunologyTherapeutic VaccineSars-cov-2-reactive Antibody WaningVaccine EfficacyImmunotherapyMedicineCell TransplantationCovid-19